Upcoming in 2012
I'll put in stickys, pending any suggested changes. Note, not much known news event in the first several months of the year. Things pick up in June.
Upcoming Events 2012
With other contributions from Bx’dad, bw1, and Don_Shimodas lists…
Upcoming trial events in 2012
- Pona in Japan
- new PH2 trial for Pona (ALL)
- Announcement of full enrollment of Phase I ‘113
- Rida Approval
- European Acceptance RIDA
- Ponatinib reg Trial data, NDA
- AP113 1st Interim Data
- Head to head against Gleevec
- New IND for Pona, solid tumor
- New indication PH3 trial for Rida (Endometrial or combo)
Announced or Probable Presentations
- JPMorgan Jan 10 San Francisco
- ASCO 2012 Chicago June 1-5
- Sept Jefferies
- Sept Rodman
- Oct Newsmaker conf
- Nov Lazard
- Dec BioFEST Deutsche
- Dec ASH
Potential wildcards:
- At any time, announcements of new initiatives, exec and corp news
- Positive news on Bellicum, IPO, etc.
- New 4th molecule announcement
- Announcement of single patient(s) trials and/or formal expanded access program to facilitate companionate use for T315I
- Buyout?
Financial News
- Q1 3/31/12 Apr/May
- Annual Meeting
- Q2 6/30/12 Aug
- Q3 9/30/12 Nov
